1952
DOI: 10.1001/archinte.1952.00240030017003
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Thyrotoxicosis With 1-Methyl-2-Mercaptoimidazole

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1952
1952
1956
1956

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(1 citation statement)
references
References 4 publications
0
1
0
Order By: Relevance
“…Irwin, Van Vactor and Norris (27) feel that the length of time required to bring the patient to a euthyroid state varies directly with the size of the goiter. Bartels (28, 29) and Kendrick, Balls and Rose (30) are of the opinion that with antithyroid compounds it takes longer to control the nodular than the diffusely hyperplastic goiter. On the other hand, the present data, and our own experience with antithyroid compounds (31, 32, 33) are in accord with the conclusion of Hallman and Bondy (34), who state that neither a longer period of time nor a larger dose of drug are necessary to control toxic nodular goiter as compared with toxic diffuse hyperplastic goiter.…”
Section: Discussionmentioning
confidence: 99%
“…Irwin, Van Vactor and Norris (27) feel that the length of time required to bring the patient to a euthyroid state varies directly with the size of the goiter. Bartels (28, 29) and Kendrick, Balls and Rose (30) are of the opinion that with antithyroid compounds it takes longer to control the nodular than the diffusely hyperplastic goiter. On the other hand, the present data, and our own experience with antithyroid compounds (31, 32, 33) are in accord with the conclusion of Hallman and Bondy (34), who state that neither a longer period of time nor a larger dose of drug are necessary to control toxic nodular goiter as compared with toxic diffuse hyperplastic goiter.…”
Section: Discussionmentioning
confidence: 99%